✦ LIBER ✦

Pharmacokinetic study in a phase I trial with an alkylating agent, diacetyldianhydrogalactitol (DADAG)

✍ Scribed by V. Erdélyi-Tóth; S. Kerpel-Fronius; B. Kanyár; S. Eckhardt

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relation between dose, plasma concentrat

✍ S. Kerpel-Fronius; V. Erdélyi-Tóth; F. Gyergyay; I. Hindy; Z. Mechl; M. Nekulová 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 563 KB

A phase I/II trial and pharmacokinetic s

✍ David M. Peereboom; Jeffrey G. Supko; Kathryn A. Carson; Tracy Batchelor; Surasa 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 187 KB

A phase I and pharmacokinetic study of i

✍ Dittrich, C; Zandvliet, A S; Gneist, M; Huitema, A D R; King, A A J; Wanders, J 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

Phase II trial and pharmacokinetic study

✍ Lissandra Dal Lago; Marc F. Richter; Anna I. Cancela; Sabrina A. Fernandes; Keyl 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 82 KB

A phase I trial of pharmacokinetic modul

✍ Apurva A. Desai; Federico Innocenti; Linda Janisch; Mark DeMario; Dale Shepard; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 229 KB

Phase I trial with weekly EO9, a novel b

✍ S. Aamdal; B. Lund; I. Koier; M. Houten; J. Wanders; J. Verweij 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 78 KB